Marcello Damiani
Director/Board Member chez BENEVOLENTAI
Profil
Marcello Damiani is currently the Director at Cellarity Inc. and an Independent Non-Executive Director at BenevolentAI SA. He is also the Chief Digital & Operational Excellence Officer at ModernaTX, Inc. Previously, he worked as the Chief Information Officer & Senior Vice President at bioMérieux SA from 2010 to 2015.
He also held the position of Chief Digital & Operational Excellence Officer at Moderna, Inc. Mr. Damiani has a graduate degree from Université Fédérale Toulouse Midi-Pyrénées and an MBA from Trium Global Emba.
Postes actifs de Marcello Damiani
| Sociétés | Poste | Début |
|---|---|---|
| BENEVOLENTAI | Director/Board Member | 04/05/2023 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 01/01/2019 |
Anciens postes connus de Marcello Damiani
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMÉRIEUX | Chief Tech/Sci/R&D Officer | 01/01/2015 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Formation de Marcello Damiani
| Université Fédérale Toulouse Midi-Pyrénées | Graduate Degree |
| Trium Global Emba | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOMÉRIEUX | Health Technology |
| MODERNA, INC. | Health Technology |
| BENEVOLENTAI | Health Technology |
| Entreprise privées | 2 |
|---|---|
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
